tiprankstipranks
Trending News
More News >
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
US Market

Eledon Pharmaceuticals (ELDN) Income Statement

Compare
979 Followers

Eledon Pharmaceuticals Income Statement

Last quarter (Q3 2025), Eledon Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Eledon Pharmaceuticals's net income was $-17.46M. See Eledon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -359.00K$ -374.00K$ -373.00K$ -195.00K$ -183.00K
Operating Expenses
$ 70.22M$ 42.63M$ 39.41M$ 36.67M$ 13.10M
Depreciation and Amortization
$ 359.00K$ 374.00K$ 373.00K$ 195.00K$ 183.00K
EBITDA
$ -35.39M$ -116.16M$ -87.59M$ -36.66M$ -23.03M
Operating Income
$ -70.58M$ -43.00M$ -39.78M$ -36.87M$ -13.28M
Other Income/Expenses
$ 34.82M$ -73.54M$ -48.19M$ 7.00K$ -9.93M
Pretax Income
$ -35.75M$ -116.54M$ -87.97M$ -36.86M$ -23.21M
Net Income
$ -36.18M$ -116.54M$ -87.97M$ -34.51M$ -22.81M
Per Share Metrics
Basic EPS
$ -0.75$ 0.00$ -6.13$ -2.33$ -15.72
Diluted EPS
$ -0.75$ -1.64$ -6.13$ -2.33$ -15.72
Weighted Average Shares Outstanding
48.54M 24.62M 14.29M 14.82M 1.45M
Weighted Average Shares Outstanding (Diluted)
48.54M 24.62M 14.29M 14.82M 1.45M
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History